ERK3 is involved in regulating cardiac fibroblast function
Physiological Reports · 2024-06 · 12 (11)
DOI: 10.14814/phy2.16108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, online erschienen am 14.06.2024. Verfasst von Pramod Sahadevan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Montreal Heart Institute, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Cardiomegaly, Mitogen-Activated Protein Kinase 6, Fibroblasts, Myocardium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heart and Stroke Foundation of Canada (HSF), Gouvernement du Canada | Canadian Institutes of Health Research (IRSC), Canadian Institutes of Health Research.
Abstract (Originalsprache)
ERK3/MAPK6 activates MAP kinase‐activated protein kinase (MK)‐5 in selected cell types. Male MK5 haplodeficient mice show reduced hypertrophy and attenuated increase in Col1a1 mRNA in response to increased cardiac afterload. In addition, MK5 deficiency impairs cardiac fibroblast function. This study determined the effect of reduced ERK3 on cardiac hypertrophy following transverse aortic constriction (TAC) and fibroblast biology in male mice. Three weeks post‐surgery, ERK3, but not ERK4 or p38α, co‐immunoprecipitated with MK5 from both sham and TAC heart lysates. The increase in left ventricular mass and myocyte diameter was lower in TAC‐ERK3 +/− than TAC‐ERK3 +/+ hearts, whereas ERK3 haploinsufficiency did not alter systolic or diastolic function. Furthermore, the TAC‐induced increase in Col1a1 mRNA abundance was diminished in ERK3 +/− hearts. ERK3 immunoreactivity was detected in atrial and ventricular fibroblasts but not myocytes. In both quiescent fibroblasts and “activated” myofibroblasts isolated from adult mouse heart, siRNA‐mediated knockdown of ERK3 reduced the TGF‐β‐induced increase in Col1a1 mRNA. In addition, intracellular type 1 collagen immunoreactivity was reduced following ERK3 depletion in quiescent fibroblasts but not myofibroblasts. Finally, knocking down ERK3 impaired motility in both atrial and ventricular myofibroblasts. These results suggest that ERK3 plays an important role in multiple aspects of cardiac fibroblast biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Montreal Heart Institute, Montréal, Québec, Canada.
- Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada.
- Department of Pharmacology and Physiology, Université de Montréal, Montréal, Québec, Canada.
- Department of Physiology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
- Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
- Department of Medicine, Université de Montréal, Montréal, Québec, Canada.
ORCID-Profile: Bruce G Allen
Förderung
- Heart and Stroke Foundation of Canada (HSF)
- Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
- Canadian Institutes of Health Research
Zitieren
APA
Sahadevan, P., Dingar, D., Nawaito, S. A., Nair, R. S., Trépanier, J., Sahmi, F., Shi, Y., Gillis, M. A., Sirois, M. G., Meloche, S., Tardif, J. C., & Allen, B. G. (2024). ERK3 is involved in regulating cardiac fibroblast function. Physiological Reports, 12(11). https://doi.org/10.14814/phy2.16108
Vancouver
Sahadevan P, Dingar D, Nawaito SA, Nair RS, Trépanier J, Sahmi F, et al. ERK3 is involved in regulating cardiac fibroblast function. Physiological Reports. 2024;12(11). doi:10.14814/phy2.16108
BibTeX
@article{Sahadevan2024,
author = {Sahadevan, Pramod and Dingar, Dharmendra and Nawaito, Sherin A and Nair, Reshma S and Trépanier, Joëlle and Sahmi, Fatiha and Shi, Yanfen and Gillis, Marc-Antoine and Sirois, Martin G and Meloche, Sylvain and Tardif, Jean-Claude and Allen, Bruce G},
title = {ERK3 is involved in regulating cardiac fibroblast function},
journal = {Physiological Reports},
year = {2024},
volume = {12},
number = {11},
doi = {10.14814/phy2.16108}
}
EUVIMED